Forte Biosciences (FBRX) Net Margin (2017 - 2019)
Forte Biosciences (FBRX) reported Net Margin of -117588.89% for Q4 2019, up 100222.22 percentage points from -217811.11% a year earlier but down 109922.22 percentage points from the prior quarter.
Powered by 
Analysis
Forte Biosciences (FBRX) Net Margin (2017 - 2019) Analysis & Trends
For FY2019, Forte Biosciences posted Net Margin of -11302.78%, down 11031.35 percentage points from FY2018.
- Net Margin has a three-year change of +57019.67 percentage points (FY2016 to FY2019).
- By year, Net Margin came in at -271.43% in FY2018 (+94677.35 pp), -94948.78% in FY2017 (-26626.33 pp) and -68322.45% in FY2016.
- Five-year quarterly Net Margin spans a low of -217811.11% in Q4 2018 and a high of -2.13% in Q3 2018.
- Year over year, Net Margin gained in four of the last seven quarters, with an average year-over-year change of +42321.27 percentage points.
- Per Business Quant data, the three quarters before Q4 2019 came in at -7666.67% (Q3 2019), -7000.00% (Q2 2019) and -13166.67% (Q1 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Forte Biosciences | 1.58 Bn | 1.38 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | -117,588.89% |
| Sep 30, 2019 | -7,666.67% |
| Jun 30, 2019 | -7,000.00% |
| Mar 31, 2019 | -13,166.67% |
| Dec 31, 2018 | -217,811.11% |
| Sep 30, 2018 | -2.13% |
| Jun 30, 2018 | -178,766.67% |
| Mar 31, 2018 | -143,111.11% |
| Dec 31, 2017 | -108,370.00% |
| Sep 30, 2017 | -99,530.00% |
| Jun 30, 2017 | -90,660.00% |
API Access
Forte Biosciences Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=FBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "FBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=FBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();